Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Cognition enhancers between treating and doping the mind.

Lanni C, Lenzken SC, Pascale A, Del Vecchio I, Racchi M, Pistoia F, Govoni S.

Pharmacol Res. 2008 Mar;57(3):196-213. doi: 10.1016/j.phrs.2008.02.004. Epub 2008 Feb 15. Review.

PMID:
18353672
2.

[Neuro-enhancement. Brain doping].

Förstl H.

Nervenarzt. 2009 Jul;80(7):840-6. doi: 10.1007/s00115-009-2801-6. Review. German.

PMID:
19565292
3.

Part II. Cognitive domains for pharmacological intervention: implications for neuropsychiatric and neurological illnesses.

[No authors listed]

Handb Exp Pharmacol. 2015;228:157-9. No abstract available.

PMID:
26317140
4.

Attention.

Callahan PM, Terry AV Jr.

Handb Exp Pharmacol. 2015;228:161-89. doi: 10.1007/978-3-319-16522-6_5. Review.

PMID:
25977082
5.

Closing thoughts for cognitive enhancement.

Kantak KM, Wettstein JG.

Handb Exp Pharmacol. 2015;228:451-9. doi: 10.1007/978-3-319-16522-6_16.

PMID:
25977093
6.

[Neuro-enhancement from an addiction specialist's viewpoint].

Soyka M.

Nervenarzt. 2009 Jul;80(7):837-9. doi: 10.1007/s00115-009-2800-7. Review. German.

PMID:
19543877
7.

Smart drugs and synthetic androgens for cognitive and physical enhancement: revolving doors of cosmetic neurology.

Frati P, Kyriakou C, Del Rio A, Marinelli E, Vergallo GM, Zaami S, Busardò FP.

Curr Neuropharmacol. 2015 Jan;13(1):5-11. doi: 10.2174/1570159X13666141210221750. Review.

8.

Signaling pathways relevant to cognition-enhancing drug targets.

Ménard C, Gaudreau P, Quirion R.

Handb Exp Pharmacol. 2015;228:59-98. doi: 10.1007/978-3-319-16522-6_3. Review.

PMID:
25977080
9.

Animal paradigms to assess cognition with translation to humans.

Wallace TL, Ballard TM, Glavis-Bloom C.

Handb Exp Pharmacol. 2015;228:27-57. doi: 10.1007/978-3-319-16522-6_2. Review.

PMID:
25977079
10.
11.

Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.

Barak S, Weiner I.

Pharmacol Biochem Behav. 2011 Aug;99(2):164-89. doi: 10.1016/j.pbb.2011.03.011. Epub 2011 Mar 21. Review.

PMID:
21420999
12.

Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people.

Ilieva I, Boland J, Farah MJ.

Neuropharmacology. 2013 Jan;64:496-505. doi: 10.1016/j.neuropharm.2012.07.021. Epub 2012 Aug 1.

PMID:
22884611
13.

Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.

Cakic V.

J Med Ethics. 2009 Oct;35(10):611-5. doi: 10.1136/jme.2009.030882. Erratum in: J Med Ethics. 2009 Dec;35(12):738.

PMID:
19793941
14.

Declarative memory.

Riedel WJ, Blokland A.

Handb Exp Pharmacol. 2015;228:215-36. doi: 10.1007/978-3-319-16522-6_7. Review.

PMID:
25977084
15.

Exploring the role of "Brahmi" (Bocopa monnieri and Centella asiatica) in brain function and therapy.

Shinomol GK, Muralidhara, Bharath MM.

Recent Pat Endocr Metab Immune Drug Discov. 2011 Jan;5(1):33-49. Review.

PMID:
22074576
16.

Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review.

Fond G, Micoulaud-Franchi JA, Brunel L, Macgregor A, Miot S, Lopez R, Richieri R, Abbar M, Lancon C, Repantis D.

Psychiatry Res. 2015 Sep 30;229(1-2):12-20. doi: 10.1016/j.psychres.2015.07.006. Epub 2015 Jul 8. Review.

PMID:
26187342
17.

Emerging cognitive enhancing drugs.

Buccafusco JJ.

Expert Opin Emerg Drugs. 2009 Dec;14(4):577-89. doi: 10.1517/14728210903257796. Review.

PMID:
19772371
18.

COMT as a drug target for cognitive functions and dysfunctions.

Scheggia D, Sannino S, Scattoni ML, Papaleo F.

CNS Neurol Disord Drug Targets. 2012 May;11(3):209-21. Review.

PMID:
22483296
19.

The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Mereu M, Bonci A, Newman AH, Tanda G.

Psychopharmacology (Berl). 2013 Oct;229(3):415-34. doi: 10.1007/s00213-013-3232-4. Epub 2013 Aug 10. Review.

20.

Expectations regarding cognitive enhancement create substantial challenges.

Racine E, Forlini C.

J Med Ethics. 2009 Aug;35(8):469-70. doi: 10.1136/jme.2009.030460.

PMID:
19644002

Supplemental Content

Support Center